These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 16868985

  • 1. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta.
    Del Galdo F, Maul GG, Jiménez SA, Artlett CM.
    Arthritis Rheum; 2006 Aug; 54(8):2616-25. PubMed ID: 16868985
    [Abstract] [Full Text] [Related]

  • 2. The role of allograft inflammatory factor 1 in systemic sclerosis.
    Del Galdo F, Artlett CM, Jimenez SA.
    Curr Opin Rheumatol; 2006 Nov; 18(6):588-93. PubMed ID: 17053503
    [Abstract] [Full Text] [Related]

  • 3. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro.
    Del Galdo F, Jiménez SA.
    Arthritis Rheum; 2007 Oct; 56(10):3478-88. PubMed ID: 17907195
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J.
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 6. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N, Maurer B, Akhmetshina A, Venalis P, Dees C, Zerr P, Palumbo K, Zwerina J, Nevskaya T, Gay S, Distler O, Schett G, Distler JH.
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [Abstract] [Full Text] [Related]

  • 7. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H, Yamane K, Kubo M, Tamaki K.
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [Abstract] [Full Text] [Related]

  • 8. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J, Gardner H, Shearstone JR, Smith E, Trojanowska M.
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O.
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [Abstract] [Full Text] [Related]

  • 10. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.
    Ihn H, Tamaki K.
    Arthritis Rheum; 2000 Oct; 43(10):2240-7. PubMed ID: 11037883
    [Abstract] [Full Text] [Related]

  • 11. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
    Yamamoto A, Ashihara E, Nakagawa Y, Obayashi H, Ohta M, Hara H, Adachi T, Seno T, Kadoya M, Hamaguchi M, Ishino H, Kohno M, Maekawa T, Kawahito Y.
    Immunol Lett; 2011 Mar 30; 135(1-2):144-50. PubMed ID: 21040744
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O.
    Arthritis Rheum; 2007 Dec 30; 56(12):4203-15. PubMed ID: 18050252
    [Abstract] [Full Text] [Related]

  • 13. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
    Distler JH, Jüngel A, Kowal-Bielecka O, Michel BA, Gay RE, Sprott H, Matucci-Cerinic M, Chilla M, Reich K, Kalden JR, Müller-Ladner U, Lorenz HM, Gay S, Distler O.
    Arthritis Rheum; 2005 Mar 30; 52(3):856-64. PubMed ID: 15751077
    [Abstract] [Full Text] [Related]

  • 14. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
    Galindo M, Santiago B, Rivero M, Rullas J, Alcami J, Pablos JL.
    Arthritis Rheum; 2001 Jun 30; 44(6):1382-6. PubMed ID: 11407698
    [Abstract] [Full Text] [Related]

  • 15. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
    Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K.
    Arthritis Rheum; 2005 Sep 30; 52(9):2897-905. PubMed ID: 16142753
    [Abstract] [Full Text] [Related]

  • 16. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
    Otieno FG, Lopez AM, Jimenez SA, Gentiletti J, Artlett CM.
    Tissue Antigens; 2007 Jun 30; 69(6):583-91. PubMed ID: 17498268
    [Abstract] [Full Text] [Related]

  • 17. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
    Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K.
    Rheumatology (Oxford); 2006 Feb 30; 45(2):157-65. PubMed ID: 16319104
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.
    J Rheumatol; 2006 Feb 30; 33(2):275-84. PubMed ID: 16465658
    [Abstract] [Full Text] [Related]

  • 19. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R.
    Arthritis Rheum; 2007 Mar 30; 56(3):1010-20. PubMed ID: 17328080
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
    Coelho LF, de Oliveira JG, de Oliveira DB, Guedes AC, Lanna CC, Prados RZ, Ferreira PC, Bonjardim CA, Kroon EG.
    Arch Dermatol Res; 2007 Aug 30; 299(5-6):259-62. PubMed ID: 17541615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.